← Eichor
Study identifier: NCT06777875 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

COMT and OPRM1 Polymorphisms and Their Effect on Post-Operative Pain in Children

Condition: Pain · Genetic Change · Children, Only  ·  Sponsor: American University of Beirut Medical Center

PhaseN/A
Planned participants200
Who can joinAll sexes, 8 Years to 18 Years
Healthy volunteersYes

About this study

The goal of this observational study is to investigate whether the A118G single-nucleotide polymorphism (SNP) in the mu-opioid receptor1(OPRM1) and Catechol-O-methyltransferase (COMT) SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries. The main question\[s\] it aims to answer \[is\]: Do OPRM1 and COMT SNPs influence postoperative pain scores in children between the ages of 8 and 18 undergoing orthopedic, abdominal, thoracic, and plastic surgeries? Participants will be assessed for their pain scores, sedation level, the amount of postoperative analgesics received, duration of their stay in the post-anesthesia care unit, and toxicity.

This description comes directly from the study's public registry record.

Talk to the study team

Roland Kaddoum, MD  ·  01350000  ·  rk16@aub.edu.lb

Thouraya HajAli  ·  01350000  ·  th64@aub.edu.lb

Always discuss trial participation with your own doctor first.

Locations (1)

Roland KaddoumBeirut, LebanonRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06777875